UDPGA uridine 5
0
-diphosphate glucuronic acidUGT UDP-glucuronosyltransferase
UV ultraviolet
Vmax the maximal rate
REFERENCES
Ackley DC, Rockich KT, Baker TR. Metabolic stability assessed by liver microsomes
and hepatocytes. In: Yan Z, Caldwell GW editors. Methods in Pharmacology and
Toxicology: Optimization in Drug Discovery:In Vitro Method. Totowa, NJ: Human
Press Inc; 2004; p151–162.
Adediran SA. Kinetic properties of normal human erythrocyte glucose-6-phosphate
dehydrogenase dimmers. Biochimie 1991;73:1211–1218.
Andersson TB, Bredberg E, Ericsson H, Sjoberg H.An evaluation of the in vitro
metabolism data for predicting the clearance and drug-drug interaction potential of
CYP2C9 substrates. Drug Metab Dispos 2004;32:715–721.
Andersson TB, Sjoberg H, Hoffmann KJ, Boobis AR, Watts P, Edwards RJ, Lake BG,
Price RJ, Renwick AB, Gomez-Lechon MJ, Castell JV, Ingelman-Sundberg M,
Hidestrand M, Goldfarb PS, Lewis DF, Corcos L, Guillouzo A, Taavitsainen P,
Pelkonen O. An assessment of human liver-derivedin vitrosystems to predict thein
vivometabolism and clearance of almokalant. Drug Metab Dispos 2001;29:712–720.
Apic G, Ignjatovic T, Boyer S, Russell RB. Illuminating drug discovery with biological
pathways. FEBS Lett 2005;579:1872–1877.
Bargetzi MJ, Aoyama T, Gonzalez FJ, Meyer UA. Lidocaine metabolism in human
liver microsomes by cytochrome P450IIIA4. Clin Pharmacol Ther 1989;46:521–527.
Bass L, Robinson P, Bracken AJ. Hepatic elimination of flowing substrates: the
distributed model. J Theor Biol 1978;72:161–184.
Bayliss MK, Bell JA, Jenner WN, Wilson K.Prediction of intrinsic clearance of loxtidine
from kinetic studies in rat, dog and human hepatocytes. Biochem Soc Trans
1990;18:1198–1199.
Broly F, Libersa C, Lhermitte M. Mexiletine metabolismin vitroby human liver. Drug
Metab Dispos 1990;18:362–368.
Busby Jr WF, Ackermann JR, Crespi CL. Effect of methanol, ethanol, dimethyl
sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human
cytochromes P-450. Drug Metab Dispos 1999;27:246–249.
Campbell ME, Grant DM, Inaba T, Kalow W.Biotransformation of caffeine,
paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-
inducible cytochrome(s) P-450 in human liver microsomes. Drug Metab Dispos
1987;15:237–249.
Chauret N, Gauthier A, Nicoll-Griffith DA. Effect of common organic solvents onin
vitrocytochrome P450-mediated metabolic activities in human liver microsomes.
Drug Metab Dispos 1998;1:1–4.
Crespi CL, Stresser DM. Fluorometric screening for metabolism-based drug–drug
interactions. J Pharmacol Toxicol Methods 2000;44:325–331.
REFERENCES 441